Skip to content

A Research on the Hospital Pollution Control and Hygine Intervention of Chemotherapy Drugs Exposure

A Research on the Hospital Pollution Control and Hygine Intervention of Chemotherapy Drugs Exposure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01253057
Enrollment
200
Registered
2010-12-03
Start date
2010-10-31
Completion date
2011-12-31
Last updated
2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Micronuclei(MN), Sister-chromatic-exchange(SCE)

Keywords

cleaning staff, antineoplastic agents

Brief summary

Several epidemiological studies found that exposure to antineoplastic agents were associated with some reproductive, carcinogenic effects, higher rates of advance micronuclei (MN), sister-chromatic-exchange (SCE) and spontaneous abortion. Cleaning staff were potentially exposed to these agents while cleaning ward, ward toilet or other area. One medical center and one area hospitals in Taipei.Surface wipe samples were collected in the cleaning staff work area, such as ward environment and ward toilet. Urine and blood samples of subjects were collected for exposure examinations. Platinum-containing drugs (Cisplatin, Carboplatin, Oxaliplatin) were used as indicator drugs in environmental (surface wipe samples) and biological (urine and blood samples) samples. A self-administered questionnaire was used to collect demographic data, working practices, medical and contact history, and perceived work-related symptoms of cleaning staff. The results of this study will be to reduce exposure to cleaning staff.

Interventions

None listed

Sponsors

Taipei Medical University WanFang Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Only included those who signed the consent study

Exclusion criteria

* none

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026